Bendamustine
Belrapzo, Bendeka, Treanda (bendamustine) is a small molecule pharmaceutical. Bendamustine was first approved as Belrapzo on 2008-03-20. It is used to treat lymphoid leukemia and non-hodgkin lymphoma in the USA. Treanda's patents are valid until 2033-03-15 (FDA).
| Trade Name | Belrapzo, Bendeka, Treanda |
|---|---|
| Common Name | Bendamustine |
| Indication | lymphoid leukemia, non-hodgkin lymphoma |
| Drug Class | Antineoplastics (chloroethylamine derivatives) |
